These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17033537)

  • 1. The adipokine visfatin is markedly elevated in obese children.
    Haider DG; Holzer G; Schaller G; Weghuber D; Widhalm K; Wagner O; Kapiotis S; Wolzt M
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):548-9. PubMed ID: 17033537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
    Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
    Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
    Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
    Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome.
    Kolsgaard ML; Wangensteen T; Brunborg C; Joner G; Holven KB; Halvorsen B; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2009; 69(8):858-64. PubMed ID: 19929281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
    Fasshauer M; Waldeyer T; Seeger J; Schrey S; Ebert T; Kratzsch J; Lossner U; Bluher M; Stumvoll M; Faber R; Stepan H
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):69-73. PubMed ID: 18034779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
    Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
    Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
    Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in visfatin after weight loss induced by gastroplastic surgery.
    Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G
    Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin and tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome.
    Olszanecka-Glinianowicz M; Kocełak P; Janowska J; Skorupa A; Nylec M; Zahorska-Markiewicz B
    Kardiol Pol; 2011; 69(8):802-7. PubMed ID: 21850623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free fatty acids normalize a rosiglitazone-induced visfatin release.
    Haider DG; Mittermayer F; Schaller G; Artwohl M; Baumgartner-Parzer SM; Prager G; Roden M; Wolzt M
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E885-90. PubMed ID: 16735449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
    Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
    Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.
    Lin CC; Lai MM; Li TC; Li CI; Liu CS; Chen CC; Wu MT
    Diabetes Res Clin Pract; 2009 Jul; 85(1):24-9. PubMed ID: 19403191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.